- Home
- CBL vs SLP Comparison
CBL vs SLP Comparison
Compare CBL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBL
- SLP
- Stock Information
- Founded
- CBL 1978
- SLP 1996
- Country
- CBL United States
- SLP United States
- Employees
- CBL N/A
- SLP N/A
- Industry
- CBL Real Estate Investment Trusts
- SLP EDP Services
- Sector
- CBL Real Estate
- SLP Technology
- Exchange
- CBL Nasdaq
- SLP Nasdaq
- Market Cap
- CBL 771.2M
- SLP 675.9M
- IPO Year
- CBL 1993
- SLP 1997
- Fundamental
- Price
- CBL $25.51
- SLP $17.16
- Analyst Decision
- CBL
- SLP Buy
- Analyst Count
- CBL 0
- SLP 7
- Target Price
- CBL N/A
- SLP $40.40
- AVG Volume (30 Days)
- CBL 140.5K
- SLP 468.2K
- Earning Date
- CBL 08-08-2025
- SLP 07-02-2025
- Dividend Yield
- CBL 10.98%
- SLP 0.35%
- EPS Growth
- CBL 2069.88
- SLP N/A
- EPS
- CBL 2.16
- SLP 0.36
- Revenue
- CBL $528,212,000.00
- SLP $78,564,000.00
- Revenue This Year
- CBL N/A
- SLP $27.66
- Revenue Next Year
- CBL N/A
- SLP $6.75
- P/E Ratio
- CBL $11.79
- SLP $48.12
- Revenue Growth
- CBL 0.03
- SLP 21.49
- 52 Week Low
- CBL $21.10
- SLP $17.04
- 52 Week High
- CBL $33.54
- SLP $49.72
- Technical
- Relative Strength Index (RSI)
- CBL 54.33
- SLP 18.67
- Support Level
- CBL $24.33
- SLP $18.66
- Resistance Level
- CBL $26.27
- SLP $28.65
- Average True Range (ATR)
- CBL 0.52
- SLP 1.74
- MACD
- CBL 0.02
- SLP -1.05
- Stochastic Oscillator
- CBL 60.67
- SLP 3.78
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.